Vantage Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Vantage Investment Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$6.6M	Buy	27,025 +1,642	+6%	+$378K	1.38%	31
2018 Q2	$5.26M	Buy	25,383 +1,455	+6%	+$309K	1.28%	35
2018 Q1	$4.94M	Buy	23,928 +7,324	+44%	+$1.54M	1.25%	35
2017 Q4	$3.15M	Buy	16,604 +1,637	+11%	+$314K	0.73%	42
2017 Q3	$2.83M	Buy	14,967 +651	+5%	+$118K	0.73%	41
2017 Q2	$2.5M	Buy	14,316 +3,602	+34%	+$605K	0.72%	44
2017 Q1	$1.65M	Buy	10,714 +1,577	+17%	+$241K	0.54%	46
2016 Q4	$1.29M	Buy	9,137 +3,543	+63%	+$522K	0.52%	45
2016 Q3	$890K	Buy	5,594 +107	+2%	+$16.5K	0.4%	53
2016 Q2	$811K	Buy	5,487 +5,134	+1,454%	+$758K	0.34%	60
2016 Q1	$50K	Buy	353 +73	+26%	+$9.78K	0.02%	244
2015 Q4	$40K	Hold	280	–	–	0.02%	274
2015 Q3	$34K	Buy	280 +70	+33%	+$9.12K	0.02%	278
2015 Q2	$27K	Hold	210	–	–	0.01%	325
2015 Q1	$28K	Hold	210	–	–	0.01%	431
2014 Q4	$26K	Hold	210	–	–	0.01%	338
2014 Q3	$26K	Hold	210	–	–	0.02%	313
2014 Q2	$25K	Hold	210	–	–	0.02%	336
2014 Q1	$25K	Hold	210	–	–	0.02%	303
2013 Q4	$23K	Buy	+210	New	+$20.9K	0.02%	310

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vantage Investment Advisors's TMO Position: Q3 2018 in Review

Vantage Investment Advisors increased its Thermo Fisher Scientific (TMO) stake by 6.5% in Q3 2018, buying an estimated $378K and bringing the position to 27,025 shares worth $6.6M. The position accounts for 1.38% of the portfolio, ranked #31.

Vantage Investment Advisors first reported a position in TMO in Q4 2013 and has held it in 20 quarters since. 1,350 funds tracked by Wall St. Rank hold TMO as of Q3 2018.

Vantage Investment Advisors held 27,025 shares of Thermo Fisher Scientific worth $6.6M as of Q3 2018.
Vantage Investment Advisors bought 1,642 Thermo Fisher Scientific shares in Q3 2018, an estimated $378K.
Thermo Fisher Scientific made up 1.38% of Vantage Investment Advisors's portfolio in Q3 2018, its #31 holding.
Vantage Investment Advisors first reported a position in Thermo Fisher Scientific in Q4 2013 and has held it in 20 quarters since.
1,350 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2018.

Based on Vantage Investment Advisors's 13F filing for Q3 2018, filed 9 Nov 2018.